Background: Closed-loop artificial pancreas device (APD) systems are externally worn
medical devices that are being developed to enable people with type 1 diabetes to regulate …

Type 1 diabetes mellitus (T1DM) represents 5–10% of diabetes cases worldwide. The
incidence of T1DM is increasing, and there is no immediate prospect of a cure. As such …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Background: A new version of the UVA/Padova Type 1 Diabetes (T1D) Simulator is
presented which provides a more realistic testing scenario. The upgrades to the previous …

Abstract A novel Model Predictive Control (MPC) law for an Artificial Pancreas (AP) to
automatically deliver insulin to people with type 1 diabetes is proposed. The MPC law is an …

OBJECTIVE To evaluate two widely used control algorithms for an artificial pancreas (AP)
under nonideal but comparable clinical conditions. RESEARCH DESIGN AND METHODS …

Background: In the past few years, the artificial pancreas—the commonly accepted term for
closed-loop control (CLC) of blood glucose in diabetes—has become a hot topic in research …

Abstract A novel Model Predictive Control (MPC) law for the closed-loop operation of an
Artificial Pancreas (AP) to treat type 1 diabetes is proposed. The contribution of this paper is …

Objective: Zone model predictive control (MPC) has been proven to be an efficient approach
to closed-loop insulin delivery in clinical studies. In this paper, we aim to safely reduce mean …

Objective: The development of artificial pancreas (AP) technology for deployment in low-
energy, embedded devices is contingent upon selecting an efficient control algorithm for …